KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Shares Issued (2016 - 2025)

Globus Medical (GMED) has disclosed Shares Issued for 15 consecutive years, with $62.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued fell 9.42% year-over-year to $62.8 million, compared with a TTM value of $89.8 million through Dec 2025, down 18.73%, and an annual FY2025 reading of $89.8 million, down 18.73% over the prior year.
  • Shares Issued was $62.8 million for Q4 2025 at Globus Medical, up from $11.1 million in the prior quarter.
  • Across five years, Shares Issued topped out at $69.3 million in Q4 2024 and bottomed at $1.0 million in Q4 2023.
  • Average Shares Issued over 5 years is $15.9 million, with a median of $10.1 million recorded in 2021.
  • The sharpest move saw Shares Issued crashed 93.29% in 2023, then skyrocketed 6561.83% in 2024.
  • Year by year, Shares Issued stood at $3.6 million in 2021, then skyrocketed by 334.69% to $15.5 million in 2022, then plummeted by 93.29% to $1.0 million in 2023, then surged by 6561.83% to $69.3 million in 2024, then dropped by 9.42% to $62.8 million in 2025.
  • Business Quant data shows Shares Issued for GMED at $62.8 million in Q4 2025, $11.1 million in Q3 2025, and $4.7 million in Q2 2025.